The report provides a detailed analysis essential for establishing a Homovanillic Acid production plant. It encompasses all critical aspects necessary for Homovanillic Acid production, including the cost of Homovanillic Acid production, Homovanillic Acid plant cost, Homovanillic Acid production costs, and the overall Homovanillic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Homovanillic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Homovanillic Acid (HVA) is mainly used in pharmaceutical, medical, and diagnostic industries, specifically as a biomarker for neuroblastoma, a frequent malignancy in children, for its diagnosis, and follow-up. Increased HVA levels in urine can be a useful tool for doctors assessing the effectiveness of treatment since they can show the onset and course of the condition. HVA is also utilized in investigations of biochemical and pharmacological descriptions of neurodegenerative illnesses and other aspects of neurotransmitter metabolism in dopamine. Therapeutic uses of HVA and its derivatives are also under research; they include dopamine related disorder and neurodegenerative disorders.
The market for Homovanillic Acid is driven by its application as a biomarker for the diagnosis and prognosis of neuroblastoma, a frequent type of cancer in children, and this elevates the need for the product in the pharmaceutical, medical, as well as health care domain. The increasing cases of neuroblastoma also increases the need to use Homovanillic Acid. Also, its usage as an important metabolite within the field of research involving dopamine and neurodegenerative diseases increases the market demand for this compound. In addition, its use in determining metabolic stress and other neurological conditions has also contributed to more adaptation and employment for the compound. Overall, industrial Homovanillic Acid procurement is influenced by its usage as a biomarker for diagnosing and monitoring neuroblastoma, the rising cases of neuroblastoma, its utilization as an important metabolite, and its employment as an indicator of metabolic stress and other neurological conditions.
Raw Material for Homovanillic Acid Production
According to the Homovanillic Acid production plant project report, the key raw material used in the production of Homovanillic Acid includes guaiacol.
Production Process of Homovanillic Acid
The extensive Homovanillic Acid production cost report consists of the following major industrial production process:
- Production from guaiacol: The production process of Homovanillic Acid starts with the reaction of guaiacol and glyoxylic acid in the presence of aqueous NaOH to form mandelic acid. Homovanillic Acid is synthesised by the reaction of acid with 5% Palladium on carbon, in context with hydrogen gas, acetic acid and water.
Homovanillic Acid is a white to pale-brown crystalline powder having the molecular formula C9H10O4 and a molecular weight of 182.17 g/mol. It has a melting point in the range of 138-140 °C. It has a solubility of 0.00000823 [mmHg]. The value of its log P is 0.33. The value of its dissociation constant, pKa1, is 4.41, and pKa2 is 10.53 at 25 °C. Homovanillic acid, the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid, is a monocarboxylic acid. It is a metabolite of catecholamines.
